Alpha Tau Medical Ltd

Alpha Tau Medical Ltd

DRTS

Get informed when a big investor buys or sells

+ Follow
Market Cap$1.64B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Alpha Tau Medical LtdAlpha Tau Medical Ltd-14.3--210%-0.3
$14.20

Target Price by Analysts

3.4% downsideAlpha Tau Medical Target Price DetailsTarget Price
$0.03

Current Fair Value

99.8% downside

Overvalued by 99.8% based on the discounted cash flow analysis.

Share Statistics

Market cap$1.64 Billion
Enterprise Value$1.63 Billion
Dividend Yield$- (-)
Earnings per Share$-0.53
Beta1.19
Outstanding Shares90,954,000

Return

Return on Equity-210.13%ROE
Return on Assets-68.96%
Return on Invested Capital-40.47%

Valuation & Multiples

P/E Ratio-14.35P/E Ratio
PEG-4.06PEG
Price to Sales-Price to Sales
Price to Book Ratio-Price to Book Ratio
Enterprise Value to Revenue-
Enterprise Value to EBIT-32.31
Enterprise Value to Net Income-18
Total Debt to Enterprise0.01
Debt to Equity0.34Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
August 18, 2026
EPS Estimate
$-0.13
Average shareholder expectation
Revenue Estimate
$144,500
Average shareholder expectation

Next Earnings Call

Expected Date
November 19, 2026
EPS Estimate
$-0.14
Average shareholder expectation
Revenue Estimate
$368,250
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.7039 70.39%
Total Calls107,400 Infinity%
Total Puts75,600 200.00%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %4.53% 1.53%
Total Invested$29.06M 143.26%
Investors Holding57 21.00%

ESG Score

No data

About Alpha Tau Medical Ltd

2 employees